Nocturnal oxygen desaturation as a predictive risk factor for coronary restenosis after coronary intervention: Serial quantitative coronary angiography study

Circulation Journal

Volumn 69, Issue 11, 2005, Pages 1320-1326

  Hayashi, Motonori ^a   Fujimoto, Keisaku ^a   Urushibata, Kazutoshi ^a   Imamura, Hiroshi ^a   Kinoshita, Osamu ^a   Kubo, Keishi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Loss index; Nocturnal oxygen desaturation; Quantitative coronary analysis; Sleep disordered breathing

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; OXYGEN SATURATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PULSE OXIMETER; QUANTITATIVE ANALYSIS; RESTENOSIS; RISK FACTOR;

AGED; ANGIOPLASTY, BALLOON; BLOOD GAS MONITORING, TRANSCUTANEOUS; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SLEEP DISORDERS;

EID: 27644505317     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.69.1320     Document Type: Article

References (43)

1. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients: Mortality. Chest 1988; 94: 1200-1204.
2. Schafer H, Koehler U, Ploch T, Peter JH. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 1997; 111: 387-393.
3. Mooe T, Franklin KA, Wiklund U, Rabben T, Holmstrom K. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 2000; 117: 1597-1602.
4. Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 2000; 109: 562-567.
5. Ogawa A, Iwase T, Yamamoto T, Nishiyama S, Narui K, Momomura S. Improvement of Cheyne-Stokes respiration, central sleep apnea and congestive heart failure by noninvasive bilevel positive pressure and medical treatment. Circ J 2004; 68: 878-882.
6. Prabhakar NR. Sleep apneas: An oxidative stress? Am J Respir Crit Care Med 2002; 165: 859-860.
7. Ohga E, Nagase T, Tomita T, Yamaguchi Y, Yoshizumi M, Ouchi Y. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999; 87: 10-14.
8. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-939.
9. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 2002; 165: 67-70.
10. Hayashi M, Fujimoto K, Urushibata K, Uchikawa S, Imaamura H, Kubo K. Nocturnal oxygen desaturation correlates with the severity of coronary atherosclerosis in coronary artery disease. Chest 2003; 124: 936-941.
11. TIMI Study Group. Thrombolysis in Myocardial Infarction (TIMI) trial: Phase 1 findings. N Engl J Med 1985; 312: 932-936.
12. Staniforth AD, Kinnear WJ, Starling R, Cowley A. Nocturnal desaturation in patients with stable heart failure. Heart 1998; 79: 394-399.
13. Saito Y. Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Disease 2002 [Editorial]. J Atheroscler Thromb 2004; 11: 101-103.
14. th edn. New York: NYHA; 1994.
15. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1991; 14: 540-545.
16. Johns MW. Reliability and factor analysis of the Epworth sleepiness scale. Sleep 1992; 15: 376-381.
17. Vázquez JC, Tsai WH, Flemons WW, Masuda A, Brant R, Hajduk E, et al. Automated analysis of digital oximetry in the diagnosis of obstructive sleep apnoea. Thorax 2000; 55: 302-307.
18. Mancini GB, Simon SB, McGillem MJ, LeFree MT, Friedman HZ, Vogel RA. Automated quantitative coronary arteriography: Morphologic and physiologic validation in vivo of a rapid digital angiographic method. Circulation 1987; 75: 452-460.
19. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel disease: Implications for patient selection (Multivessel Angioplasty Study Group). Circulation 1990; 82: 1193-1202.
20. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB 3rd, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988; 78: 486-502.
21. Peters S, Gotting B, Trummel M, Rust H, Brattstrom A. Valsartan for prevention of restenosis after stenting of type B2/C lesions: The VAL-PREST trial. J Invasive Cardiol 2001; 13: 93-97.
22. Shinozaki T, Watanabe J, Kikuchi J, Tamaki K, Hoshi N, Hayashi M, et al. DIAST Investigators: Rationale, design, and organization of the Diastolic Heart Failure Assessment Study in Tohoku District (DIAST). Circ J 2004; 68: 660-664.
23. Banno K, Shiomi T, Sasanabe R, Otake K, Hasegawa R, Maekawa M, et al. Sleep-disordered breathing in patients with idiopathic cardiomyopathy. Circ J 2004; 68: 338-342.
24. Sjostrom C, Lindberg E, Elmasry A, Hagg A, Sverdsudd K, Janson C. Prevalence of sleep apnoea and snoring in hypertensive men: A population based study. Thorax 2002; 57: 602-607.
25. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: Population study. BMJ 2000; 320: 479-482.
26. Podszus TE. Hemodynamics in sleep apnea. Prog Clin Biol Res 1990; 345: 353-359.
27. Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999; 99: 1574-1579.
28. Reimers B, Moussa I, Akiyama T, Tucci G, Ferraro M, Martini G, et al. Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis. J Am Coll Cardiol 1997; 30: 186-192.
29. Hoffman R, Mintz GS, Dussaillant GR, Tucci G, Ferraro M, Martini G, et al. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.
30. Kornowoski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1988; 31: 224-230.
31. Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1977; 30: 1428-1436.
32. Ichikawa H, Flores S, Kvietys PR, Wolf RE, Yoshikawa T, Granger DN, et al. Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circ Res 1997; 81: 922-931.
33. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162: 566-570.
34. Peter S, David MK, Peter JL, Peter B, Meeroula B. Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 2003; 123: 1119-1126.
35. Wessendorf TE, Thilmann AF, Wang YM, Schreiber A, Konietzko N, Teschler H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000; 162: 2039-2042.
36. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 1987; 258: 1183-1186.
37. Tilkian AG, Motta J, Guilleminault C. Cardiac arrhythmias in sleep apnea. In: Guilleminault C, Dement WC, editors. Sleep apnea syndrome. New York: Alan R Liss; 1978; 197-210.
38. Stoohs R, Guilleminault C. Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol 1992; 72: 583-589.
39. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004; 291: 1071-1080.
40. Strutt K, Caplan R, Hutchison H, Dane A, Blasetto J. More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy. Circ J 2004; 68: 107-113.
41. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, et al. Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators: Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005; 352: 29-38.
42. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.
43. Lewis SJ, Sacks FM, Mitchell JS, East C, Glasser S, Kell S, et al. Effect of pravastatin on cardiovascular events in women after myocardial infarction: The cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol 1998; 32: 140-146.